Gemcitabine
NK-SYSUCC-2016
Phase 2 small_molecule active
Quick answer
Gemcitabine for Treatment Refusal is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Treatment Refusal
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active